NCT02603965View on ClinicalTrials.gov

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate CancerStage IV Prostate Cancer
Interventions
RADIATION

Copper Cu 64 TP3805

Given IV

PROCEDURE

Positron Emission Tomography

Undergo Cu-64-TP3805 PET(Positron Emission Tomography)/CT

PROCEDURE

Computed Tomography

Undergo Cu-64-TP3805 PET/CT (Computed Tomography)

PROCEDURE

Radical Prostatectomy

Undergo radical prostatectomy

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT02603965 - Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter